Gambaran Drug Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Tuminting

Abstract

Diabetes mellitus (DM) is a chronic disease with a very high complication rate and the third-highest cause of death in Indonesia. The management of DM cannot be separated from the action of drug therapy. It is necessary to have pharmaceutical care in handling drug related problems (DRPs) in order to achieve optimal drug effects on patients. The purpose of this study is to describe the characteristics and incidence of DRPs in type 2 DM patients at the Tuminting Public Health Centre, Manado. Sampling of 42 samples is conducted with a purposive sampling method using medical records and patient medical treatment history data for type 2 DM patients retrospectively from January to June 2019. The data is analyzed descriptively. The results obtained from the incidence of type 2 diabetes mellitus in women were 53.10% and men 46.90%. Most patients with type 2 diabetes were at the age of >60 years, 66.67%. The highest co-morbidity were cardiovascular disorders 24,24%. The most widely used antihyperglycemic drug was metformin 72.50%. The most DRPs incidence occurred in May 2019 at 36.36%, with 59.05% was needing drugs was, 13.64% did not need drugs, 20.45% wrong drugs, 2.27% less dose and 4.55% over dose.

Fracture Risk Assessment Tool (Frax Tool) Scores in Type 2 Diabetes Mellitus Patients in Haji Hospital Medan

“…With up to 48 respondents, the macroangiopathy comorbidity in the form of hypertension is the one with the greatest number of respondents when it comes to comorbidities (60 percent). This is exactly in line with the study by Tampa'I et al [22]. regarding the proportion of comorbidities in T2DM patients at Tuminting Health Center in January-June 2019.…”

Analysis of Therapy Satisfaction on the Quality-of-Life of Type 2 Diabetes Mellitus Patients at Anutapura Hospital Palu

“…The drug that is more widely used as the main drug is metformin, because metformin is a first-line treatment that can improve insulin sensitivity, inhibit glucose formation in the liver, reduce low-density lipoprotein (LDL) and triglycerides, and suppress appetite. Metformin has side effects, namely dyslipidemia, diarrhea, and lactic acidosis (Tampa'i et al, 2021). Based on table 5, the results of therapy satisfaction are in the category of very satisfied and good quality of life (1.0%) while with poor quality of life (0.0%), then the results of therapy satisfaction are in the category of satisfied and good quality of life (38.0%) while with poor quality of life (52.0%), then the results of therapy satisfaction were in the category quite satisfied and good quality (9.0%) while with…”

Application of Home Medication Review (HMR) on Patient Adherence in Type 2 Diabetes Mellitus (T2DM) Blood Sugar Management

“…Diabetes Mellitus is a non-communicable disease with increasing prevalence globally and nationally occupies the top ten conditions with the most causes of death and cases [1]. Diabetes mellitus is characterized by increased blood glucose levels exceeding normal and disturbances of carbohydrate, protein, and fat metabolism caused by insulin deficiency, impaired insulin response, or both [2].…”

“…The patient must carry out various arrangements related to eating arrangements, regular exercise, and blood glucose control so that it interferes with patient comfort [7]. Non-adherence of diabetes mellitus patients in treatment will impact low clinical outcomes, risk of complications, and bad quality of life [1]. Complications that occur in people with diabetes mellitus are cardiovascular disease, neuropathy retinopathy, cerebrovascular disease, nephropathy, and peripheral vascular diseases.…”